Is Roche Holding (SWX:ROG) Price Still Attractive After Strong One Year Share Performance [Yahoo! Finance]
ROCHE HOLDING LTD S/ADR (RHHBY)
NASDAQ:AMEX Investor Relations:
roche.com/investors.htm
Company Research
Source: Yahoo! Finance
Wondering whether Roche Holding's current share price still offers value, or if most of the opportunity is already priced in? This article walks through the key pieces you need to judge that for yourself. Roche Holding's shares recently closed at CHF 350.5, with returns of 1.1% over 7 days, 6.3% over 30 days, 7.7% year to date, 29.6% over 1 year and 35.7% over 3 years. These figures put recent price moves front and center in any assessment of value. Recent attention has focused on Roche Holding's position as a major global healthcare group and on how its broad pharmaceuticals and diagnostics portfolio fits into long term demand for treatments and testing. At the same time, investors are weighing how Roche Holding's established market presence sits alongside newer therapies and competitors, which helps frame the current share price. On Simply Wall St's valuation checks, Roche Holding scores 4 out of 6, which suggests the shares screen as undervalued on several measures. Next, we
Show less
Read more
Impact Snapshot
Event Time:
RHHBY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
RHHBY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
RHHBY alerts
High impacting ROCHE HOLDING LTD S/ADR news events
Weekly update
A roundup of the hottest topics
RHHBY
News
- Roche (OTCMKTS:RHHBY) had its "underweight" rating reaffirmed by analysts at Morgan Stanley.MarketBeat
- Genentech Awards Grant to Support Science Center's Translation ProjectPR Web
- SanegeneBio and Genentech sign $1.5bn global RNAi licensing deal [Yahoo! Finance]Yahoo! Finance
- Pharmaceutical Contract Development and Manufacturing Organization Forecasts Report 2026: A $374.68 Billion Market by 2031 - One-Stop CDMOs, Rapid AI Platforms, and GLP-1/HPAPI Build-Outs Drive Demand [Yahoo! Finance]Yahoo! Finance
- Genentech in up to $1.7B RNAi licensing deal with SanegeneBio [Seeking Alpha]Seeking Alpha